Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Courses
  4. ESMO - The Christie Preceptorship on Lung Cancer 2024: Manchester

Session 4 - Palliative Treatment of Lung Cancer and Mesothelioma

Beyond EGFR, ALK, ROS1 and KRAS: Novel Molecularly Driven Targeted Therapies in NSCLC

Date

07 Mar 2024

Session

Session 4 - Palliative Treatment of Lung Cancer and Mesothelioma

Topics

Pathology/Molecular Biology;  Targeted Therapy

Tumour Site

Non-Small Cell Lung Cancer

Presenters

Simon Ekman, SE

Resources

This content is available to ESMO members and event participants.
Login

Resources from the same session

Treatment of Oligometastatic NSCLC

Presenter: Lizza Hendriks, NL

Session: Session 4 - Palliative Treatment of Lung Cancer and Mesothelioma

Resources:

Slides

Webcast

Systemic Treatment of Mesothelioma

Presenter: Paul Baas, NL

Session: Session 4 - Palliative Treatment of Lung Cancer and Mesothelioma

Resources:

Slides

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.